FDA Clearance Tracker · P240013
Sphere-9 Catheter and Affera Ablation System
Last checked: Nov 19, 2026Latest source record: Oct 24, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Oct 24, 2024
Approved
Time to decision
196 days
Received Apr 11, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P240013
- Device name
- Sphere-9 Catheter and Affera Ablation System
- Applicant
- Medtronic, Inc.
- Applicant location
- Mounds View, MN
- Received
- Apr 11, 2024
- Decided
- Oct 24, 2024
- Decision
- Approved
- Supplements
- 32 in FDA's data for this PMA. See them on the FDA record
Device type
- Device class
- Class III
- Specialty
- CardiologyElectrophysiology
FDA's approval statement
As written in FDA's record.
approval for the Sphere-9 Catheter and Affera Ablation System. This device is indicated for use in cardiac electrophysiological mapping (stimulation and electrogram recording) and for treatment of drug refractory, recurrent, symptomatic persistent atrial fibrillation (episode duration less than 1 year) and radiofrequency ablation of cavotricuspid isthmus dependent atrial flutter when used with the Affera mapping system.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code QZI. The earliest in FDA's data is P230017, decided Dec 13, 2023.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Medtronic, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K263596 · Decided Oct 29, 2026 · 29 days after receipt
Device type: Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass (DWF) · Cardiology
K262913 · Decided Sep 17, 2026 · 29 days after receipt
Device type: Stents, Drains And Dilators For The Biliary Ducts (FGE) · GI, Urology & Nephrology
K262735 · Decided Aug 28, 2026 · 28 days after receipt
Device type: Recorder, Event, Implantable Cardiac, (With Arrhythmia Detection) (MXD) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.